GeneOne Life Science, Inc. (진원생명과학(주))
KOSPI Stock Code: 011000 | DART Corp Code: 00118521
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | GeneOne Life Science, Inc. |
|---|---|
| Korean legal name | 진원생명과학(주) |
| Alternate names | 진원생명과학 |
| Market | KOSPI |
| Stock Code | 011000 |
| DART Corp Code | 00118521 |
| CEO | 김경진(단독대표) |
| Business Registration No. | 1208114898 |
| Corporate Registration No. | 1101110191562 |
| Established Date | 1976-01-27 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 서울특별시 구로구 디지털로26길 5 에이스하이엔드타워1차 1403호 |
| Homepage | https://www.genels.com/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260407003512 |
| verified_at | 2026-11-01T02:16:24.909Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260407003512
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 23,044,791,670 | KRW 35,720,098,849 |
| Operating Income (영업이익) | KRW -44,036,249,294 | KRW -43,039,113,456 |
| Net Income (당기순이익) | KRW -51,850,979,601 | KRW -48,536,607,370 |
| Total Assets (자산총계) | KRW 119,207,169,002 | KRW 151,334,407,812 |
| Total Liabilities (부채총계) | KRW 78,309,107,331 | KRW 65,729,165,208 |
| Total Equity (자본총계) | KRW 40,898,061,671 | KRW 85,605,242,604 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-29 | 20261029800883 | Notice on Other Matters (Disclosure of KRX) (상장적격성 실질심사 결과 안내) | 기타시장안내 (상장적격성 실질심사 결과 안내) | 유가증권시장본부 |
2026-10-29 | 20261029000655 | [Corrected description]Report on Major Issues (Decision on sale of treasury convertible bonds) | [기재정정]주요사항보고서(자기전환사채매도결정) | 진원생명과학 |
2026-10-23 | 20261023000364 | [Corrected description]Decision on Capital Increase with Consideration | [기재정정]주요사항보고서(유상증자결정) | 진원생명과학 |
2026-10-23 | 20261023800001 | Other Management Information(Material Business matters of Subsidiary Company) | 기타경영사항(종속회사의주요경영사항) | 진원생명과학 |
2026-10-21 | 20261021800687 | Court Ruling or Decision on Lawsuit, etc. (Claim of over Certain Amount) | 소송등의판결ㆍ결정(일정금액이상의청구) | 진원생명과학 |
2026-10-15 | 20261015000225 | [Corrected description]Decision on Capital Increase with Consideration | [기재정정]주요사항보고서(유상증자결정) | 진원생명과학 |
2026-10-14 | 20261014800363 | [Corrected description]Closure of Register of Shareholders or Designation of Record Date | [기재정정]주주명부폐쇄기간또는기준일설정 | 진원생명과학 |
2026-10-14 | 20261014800361 | [Corrected description]Decision on Calling Shareholders' Meeting | [기재정정]주주총회소집결의 | 진원생명과학 |
2026-10-12 | 20261012800717 | [Corrected description]Other Management Information(Material Business matters of Subsidiary Company) | [기재정정]기타경영사항(종속회사의주요경영사항) | 진원생명과학 |
2026-10-08 | 20261008800890 | [Corrected description]Other Management Information(Material Business matters of Subsidiary Company) | [기재정정]기타경영사항(종속회사의주요경영사항) | 진원생명과학 |
2026-10-07 | 20261007000497 | Report on Major Issues (Decision on Acquisition of Treasury Convertible Bonds before Maturity) | 주요사항보고서(자기전환사채만기전취득결정) | 진원생명과학 |
2026-09-30 | 20260930000698 | [Corrected description]Decision on Capital Increase with Consideration | [기재정정]주요사항보고서(유상증자결정) | 진원생명과학 |
2026-09-28 | 20260928800707 | Notice on Other Matters (Disclosure of KRX) (기업심사위원회 개최기한 연장안내) | 기타시장안내 (기업심사위원회 개최기한 연장안내) | 유가증권시장본부 |
2026-09-23 | 20260923800336 | Other Management Information(Material Business matters of Subsidiary Company) | 기타경영사항(종속회사의주요경영사항) | 진원생명과학 |
2026-09-18 | 20260918800435 | Closure of Register of Shareholders or Designation of Record Date | 주주명부폐쇄기간또는기준일설정 | 진원생명과학 |
2026-09-18 | 20260918800429 | Decision on Calling Shareholders' Meeting | 주주총회소집결의 | 진원생명과학 |
2026-09-04 | 20260904800730 | Designation as Unfaithful Disclosure Corporation | 불성실공시법인지정 | 유가증권시장본부 |
2026-09-02 | 20260902800657 | [Corrected description]Decision on Provision of Debt Guarantee for Others | [기재정정]타인에대한채무보증결정 | 진원생명과학 |
2026-08-31 | 20260831800890 | Notice on Other Matters (Disclosure of KRX) (개선계획서 제출) | 기타시장안내 (개선계획서 제출) | 유가증권시장본부 |
2026-08-24 | 20260824000250 | [Corrected description]Decision on Capital Increase with Consideration | [기재정정]주요사항보고서(유상증자결정) | 진원생명과학 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260407003512 | verified_at: 2026-11-01T02:16:24.909Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.